Form 4: Notable Labs Director Michele Galen Reports Acquisition of 40,247 Ordinary Shares

Director Michele Galen reports acquiring 40,247 ordinary shares of Notable Labs, Ltd. through a grant of restricted shares.

Summary

• On May 8, 2024, Michele Galen, a director of Notable Labs, Ltd., reported acquiring 40,247 ordinary shares.
• The acquisition was a grant of restricted shares.
• The shares vest in two equal annual installments from the date of the grant.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of share acquisition by a director. The vesting schedule suggests a long-term commitment, which is mildly positive.

Positives

• The acquisition of shares by a director could be seen as a positive sign, indicating confidence in the company's future.

Future Outlook

The restricted shares vest in two equal annual installments from the date of grant, suggesting a longer-term commitment from the director.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This allows investors to track the buying and selling activity of individuals with access to non-public information.

Key Dates

Keywords

Notable Labs, Director, Share Acquisition, Form 4, Restricted Shares, Michele Galen